MedTrace Logo

Study of Diabetes' Risk Factors and Accelerated Aging According to Socio-economic Status in a Population From the North of France

NCT05717491 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2014

Last updated 2024-04-22

No results posted yet for this study

Summary

Populations in precarious situations or with low socio-economic status have an increased risk of diabetes and accelerated aging. According to the population studied, the elements that can explain these health inequalities are not unequivocal and remain poorly known.

The north of France, particularly affected by socio-economic disparities, has a prevalence of diabetes among the highest in metropolitan France. This is why investigators want to study the clinical, biological, social and behavioural risk factors of the entry into diabetes and accelerated aging among a large population in the North of France.

This study aims to characterize the population (among which a majority (55%) suffers from precarious conditions) who come to carry out their health examination at the Pasteur Institute in Lille in order to study the risk factors to better explain these health inequalities.

This research consists of a main descriptive observational, cross-sectional study carried out on 2233 volunteers (main group) over 18 months, and a complementary analytical case-control study that will be offered to 216 participants (sub-group).

Conditions

Interventions

OTHER

Biological analysis, Physical examination and Questionnaires

Biological analysis, Physical examination and questionnaires will be performed for all patients of the main group.

OTHER

Physical examination and Questionnaires

In addition to exams for the main group, there will be 2 additional examinations (bone densitometry and arterial stiffness) for the patients of the subgroup and others questionnaires.

Sponsors & Collaborators

  • National Center for Precision Diabetic Medicine,PreciDIAB

    collaborator UNKNOWN

  • Institut Pasteur de Lille

    lead OTHER

Principal Investigators

  • Philippe Dr FROGUEL, PhD · PRECIDIAB

  • Matthias Mr VANDESQUILLE, PhD · PRECIDIAB

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-14
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05717491 on ClinicalTrials.gov